Monsanto Agrees to Cross-Licensing Deal with Bayer

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

In exchange for being granted licenses to evaluate enabling technologies for corn rootworm control and herbicide tolerance, Monsanto (NYSE: MON  ) agreed to provide Bayer CropScience with a royalty-bearing cross-license to its Genuity Roundup Ready 2 Yield and Genuity Roundup Ready 2 Xtend technology in soybeans in the U.S. and Canada.

Bayer will also receive a royalty-bearing license to Intacta RR2 PRO in soybeans in Brazil, with an option on a royalty-bearing license in other Latin American countries in the future. Bayer CropScience has also been granted stacking rights under certain conditions.

Genuity Roundup Ready 2 Yield is Monsanto's second-generation trait-technology platform for soybeans. Its Genuity Roundup Ready 2 Xtend soybeans contains the Yield trait technology stacked with a trait that provides tolerance to herbicide dicamba. Intacta RR2 PRO soybeans are the first‐ever insect-protected trait in soybeans, providing control of lepidopteran pests, such as moths and butterflies.

Rudiger Scheitza, a member of Bayer CropScience's board of management, said, "We are excited that with the combined technologies from both companies, we will be able to offer farmers additional pest control options and an all-inclusive weed resistance package in soybeans."

Monsanto's president and chief commercial officer, Brett Begemann, said, "We're pleased we have been able to reach an agreement with Bayer CropScience, which will offer increased benefits for farmers and foster continued choice and innovation in our industry."

Additional terms and financial details of the agreements were not disclosed.

Bayer CropScience, a subsidiary of Bayer AG responsible for the agricultural business, had annual sales of 8,383 million euros in 2012. Monsanto realized more than $14.7 billion in revenues over the past 12 months.

Read/Post Comments (1) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2366728, ~/Articles/ArticleHandler.aspx, 9/28/2016 11:39:31 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,199.78 -28.52 -0.16%
S&P 500 2,154.12 -5.81 -0.27%
NASD 5,292.16 -13.55 -0.26%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/28/2016 11:24 AM
MON $102.21 Down -0.04 -0.04%
Monsanto CAPS Rating: ***